UK markets close in 3 hours 52 minutes

Ypsomed Holding AG (0QLQ.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
337.50-14.54 (-4.13%)
As of 12:12PM BST. Market open.

Ypsomed Holding AG

Brunnmattstrasse 6
Burgdorf 3401
Switzerland
41 34 424 41 11
https://www.ypsomed.com

Sector(s)
Industry
Full-time employees2,200

Key executives

NameTitlePayExercisedYear born
Mr. Simon MichelMember of the Board1.14MN/A1977
Mr. Niklaus RamseierChief Financial OfficerN/AN/A1963
Mr. Frank MengisChief Operating OfficerN/AN/A1964
Thomas KuttHead of Investor RelationsN/AN/AN/A
Dr. Nicolas MeyerChief Legal OfficerN/AN/A1971
Mr. Michael ZauggChief Corporate OfficerN/AN/A1972
Ms. Ulrike BauerChief Business Officer of Ypsomed Delivery SystemsN/AN/A1969
Mr. Sebastien DelariveChief Business Officer of Ypsomed Diabetes CareN/AN/A1969
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Corporate governance

Ypsomed Holding AG’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 7; Board: 3; Shareholder rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.